Purchases and Sales Made in Q3 2024 in Acadia Pharmaceuticals Inc (ACAD)
This table provides information about the institutional ownership of Acadia Pharmaceuticals Inc (ACAD) during Q3 2024. The information is specifically focused on institutions that hold shares of ACADIA PHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 12, 2024
Q3 2024
|
Jupiter Asset Management LTD
|
SELL
|
- |
-903K- 85.16% |
$13.7M - $17.3M
|
157K
$2.58M
|
|
|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-1.59M- 57.16% |
$24M - $30.4M
|
1.19M
$19.5M
|